Chenomx Inc. We offer a proprietary platform for generating, classifying, and interpreting metabolic information obtained from biological fluids using nuclear magnetic resonance (NMR) spectroscopy. We combine state-of-the-art spectroscopic technology for identifying metabolic markers with advanced algorithms for analyzing biological samples. Our technology platform is available through two channels: software licensing and contract services.